(Q46220313)

English

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Alzheimer's disease

0 references

author name string

Amy Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

James Paskavitz

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Ruth Remington

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Shelly Rasmussen

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Thomas B Shea

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

American Journal of Alzheimer's Disease & Other Dementias

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

23

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

571-585

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

Treatment of Alzheimer's disease across the spectrum of severity

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Pharmacotherapy of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Is functional decline necessary for a diagnosis of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Prevention trials in Alzheimer disease: one step forward?

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease (AD).

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Mediterranean diet and cognitive decline.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Causes of oxidative stress in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Glutathione metabolism during aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Implications on human fertility of the 677C-->T and 1298A-->C polymorphisms of the MTHFR gene: consequences of a possible genetic selection

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Relationship between dementia and nutrition-related factors and disorders: an overview

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Diet and Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Folic acid with or without vitamin B12 for cognition and dementia

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E, and apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Folate deprivation increases presenilin expression, gamma-secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S-adenosyl methionine

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge: relevance to age-related neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Effect of S-adenosyl-L-methionine on rat brain oxidative stress damage in a combined model of permanent focal ischemia and global ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Normative data for the Mattis Dementia Rating Scale

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: a double cross-validation and application to a community-dwelling sample

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

CLOX: an executive clock drawing task

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Assessment of behavioural and psychological symptoms associated with dementia

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

What causes problems in Alzheimer's disease: attributions by caregivers. A qualitative study.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Caregiver's distress is associated with delusions in Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patient

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325093

21 January 2018

Identifiers

10.1177/1533317508325093

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

release_cfhkn22xdvb2vfkwfsgweflddy

1 reference

https://api.fatcat.wiki/v0/release/cfhkn22xdvb2vfkwfsgweflddy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19047474

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46220313&oldid=2100118427"